http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2251427-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1dfd39878009ed672c93ba0247ee666 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 |
filingDate | 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b225fe35ff8468d05e26ea71dbc828c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff3c7e90317d515221ac36601416907a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a44a8c3ec29c5adec78149eedf1e23b6 |
publicationDate | 1999-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2251427-A1 |
titleOfInvention | Synthetic amyloid enhancing composition |
abstract | Synthetic amyloid enhancing compositions for inducing amyloidosis in a subject are described. Methods are described for using synthetic amyloid enhancing compositions to induce a subject to have increased amyloid deposition. Methods for administering to a subject an effective amount of a synthetic amyloid enhancing composition in conjunction with inflammatory stimulus to induce amyloidosis are provided. Compositions for inducing amyloidosis in a subject are described. The composition includes an effective amount of a synthetic amyloid enhancing composition in a pharmaceutically acceptable carrier. Other aspects describe packaged synthetic amyloid enhancing compositions for inducing amyloidosis. |
priorityDate | 1997-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.